You are here

  • Home
  • Archive
  • Volume 11, Issue 7
  • Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

Article metrics

Article menu
XML
Diabetes and endocrinology
Original research
Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

 

Online download statistics by month:

Online download statistics by month: July 2021 to April 2024

AbstractFullPdf
Jul 2021796786198
Aug 2021175173112
Sep 202113512842
Oct 202110810229
Nov 202111210326
Dec 20211049532
Jan 202210410038
Feb 2022898538
Mar 2022908933
Apr 2022705839
May 2022948641
Jun 2022665730
Jul 2022534933
Aug 2022999130
Sep 2022463728
Oct 2022806925
Nov 2022786527
Dec 2022393217
Jan 2023636026
Feb 2023494624
Mar 2023363318
Apr 2023272324
May 2023433819
Jun 2023434122
Jul 2023635731
Aug 2023433624
Sep 2023323020
Oct 2023342816
Nov 2023545319
Dec 2023696126
Jan 2024695421
Feb 2024685824
Mar 2024887649
Apr 2024787122
Total319729701203